Financial Avengers’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.23M | Sell |
1,580
-3
| -0.2% | -$2.34K | 0.57% | 25 |
|
2025
Q1 | $1.31M | Buy |
1,583
+128
| +9% | +$106K | 0.66% | 24 |
|
2024
Q4 | $1.12M | Sell |
1,455
-42
| -3% | -$32.4K | 0.53% | 24 |
|
2024
Q3 | $1.33M | Sell |
1,497
-189
| -11% | -$167K | 0.65% | 21 |
|
2024
Q2 | $1.53M | Buy |
1,686
+1,343
| +392% | +$1.22M | 0.81% | 19 |
|
2024
Q1 | $261K | Buy |
343
+1
| +0.3% | +$760 | 0.14% | 28 |
|
2023
Q4 | $200K | Hold |
342
| – | – | 0.12% | 29 |
|
2023
Q3 | $184K | Buy |
342
+1
| +0.3% | +$537 | 0.12% | 32 |
|
2023
Q2 | $160K | Buy |
341
+1
| +0.3% | +$469 | 0.11% | 33 |
|
2023
Q1 | $117K | Buy |
340
+1
| +0.3% | +$344 | 0.09% | 34 |
|
2022
Q4 | $124K | Buy |
339
+1
| +0.3% | +$366 | 0.1% | 32 |
|
2022
Q3 | $109K | Buy |
338
+127
| +60% | +$41K | 0.09% | 31 |
|
2022
Q2 | $68K | Sell |
211
-232
| -52% | -$74.8K | 0.06% | 45 |
|
2022
Q1 | $127K | Buy |
443
+1
| +0.2% | +$287 | 0.08% | 37 |
|
2021
Q4 | $122K | Buy |
442
+107
| +32% | +$29.5K | 0.07% | 41 |
|
2021
Q3 | $77K | Buy |
335
+1
| +0.3% | +$230 | 0.05% | 49 |
|
2021
Q2 | $77K | Buy |
334
+1
| +0.3% | +$231 | 0.05% | 50 |
|
2021
Q1 | $62K | Buy |
333
+2
| +0.6% | +$372 | 0.05% | 56 |
|
2020
Q4 | $56K | Buy |
+331
| New | +$56K | 0.05% | 52 |
|